Clinical trials are currently experiencing a quiet renaissance that is fundamentally changing the way medical research captures and quantifies patient experience data. As regulators increasingly ...

Operational real-world data analyzed from patients prescribed ZYNTEGLO™ and LYFGENIA™ Data demonstrates the value proposition of one-time, durable gene therapy for the treatment of sickle cell disease ...

The pharmaceutical industry invests billions of dollars 1 in digital tools and technologies. But for all the online surveys, feedback loops, and digital portals introduced to improve the patient ...

The health policy landscape continues to evolve, creating new opportunities to advance meaningful progress, especially on issues that have long been on the policy agenda, such as ensuring patient ...

LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- OutcomeMD ®, a leader in transforming healthcare through patient-reported outcomes, today launched the Patient Experience Data Network ™, the industry's first ...

As Europe grapples with the growing burden of neurological conditions, regulators are being forced to confront a fundamental question: how should patient outcomes be defined and measured for brain ...

Patient engagement has matured from aspiration to necessity as precision medicine moves from laboratory concept to bedside. Cutting-edge therapies increasingly target narrowly defined genetic or ...

As we come to the end of another year, the changes and challenges of 2025 could yield opportunities for patient experience work in 2026. At the start of this year, we anticipated the launch of a new ...

Operational real-world data analyzed from patients prescribed ZYNTEGLO™ and LYFGENIA™ Oral presentation of recent patient experience data demonstrating the value proposition of gene therapy More than ...

Patient experience (PX) has become a key concern for hospitals in the US. The Centers for Medicare & Medicaid Services (CMS) will use patient feedback about their care as part of their reimbursement ...